Treatment strategies for polycythemia vera: Observations in a Dutch "real-world" cohort study.

Claire van de Ree-PellikaanArne de KreukCees G SchaarAart BeekerEllen C DompelingCees J H GerritsAnja A van HoutenMartin R SchipperusLeonie StrobbeEduardus F M PosthumaKarin KlaukePeter E Westerweel

Published in: European journal of haematology (2019)

In Dutch clinical practice, there is major clinical variation in treatment strategies for PV. Phlebotomizing patients shorten the time to achieve hematocrit control, while HU better controls platelet and leukocyte levels. The thrombotic vascular event rate remains clinically significant.

Keyphrases

clinical practice
ejection fraction
newly diagnosed
prognostic factors
peripheral blood
patient reported outcomes